Evolent Health (EVH) Price & Analysis

Compare

717 Followers

EVH Stock Chart & Stats

Day’s Range― - ―

52-Week Range$7.06 - $31.80

Previous CloseN/A

Volume268.11K

Average Volume (3M)3.27M

Market Cap

$1.12B

Enterprise Value$2.21B

Total Cash (Recent Filing)$151.00M

Total Debt (Recent Filing)$204.74M

Price to Earnings (P/E)―

Beta0.22

Next Earnings

Oct 29, 2025

EPS Estimate

0.09

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.10

Shares Outstanding117,508,720

10 Day Avg. Volume3,259,129

30 Day Avg. Volume3,267,096

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market Cap1.98

Enterprise Value/Revenue1.01

Enterprise Value/Gross Profit6.58

Enterprise Value/Ebitda209.48

Forecast

1Y Price Target

$15.25

Price Target Upside60.70% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering12

Bulls Say, Bears Say

Bulls Say

Financial PerformanceEvolent Health beat second quarter estimates and raised its 2025 adjusted EBITDA guidance.

Market OpportunityThe company continues to showcase strong contract growth momentum, highlighting new revenue agreements with CVS/Aetna and existing clients.

Revenue PotentialManagement reiterated its confidence in $2.5 billion revenue target for 2026 with its roughly $1 billion current weighted pipeline.

Bears Say

Membership ImpactMedicaid work requirement impact could reduce membership by less than 5% and affect adjusted EBITDA by $8-10M.

Quarterly PerformanceEvolent Health reported somewhat mixed second quarter 2025 earnings, with revenue coming in toward the low end of guidance and modestly below the Street.

Revenue GuidanceRevenue guidance was lowered by $220M due to two PS delays, including a contract delay with AET.

Evolent Health News

Evolent Health management to meet with Piper Sandler

Meeting to be held on September 3 hosted by Piper Sandler. Published first on TheFly – the ultimate...

4d ago

EVH

Evolent Health price target raised to $18 from $16 at Piper Sandler

Piper Sandler raised the firm’s price target on Evolent Health (EVH) to $18 from $16 and keeps an...

9d ago

EVH

Evolent Health prices upsized $145M convertible senior note debt

Evolent Health (EVH) announced the pricing of $145.0 million aggregate principal amount of 4.50% convertible senior notes due...

18d ago

EVH

Closing Bell Movers: Palo Alto Networks jumps 5% on Q4 earnings beat

In the opening hour of the evening session, U.S. equity futures are up slightly, with S&P 500, Nasdaq...

18d ago

Evolent Health announces $140M convertible senior notes offering

Evolent Health (EVH) announced that it intends to offer $140M aggregate principal amount of convertible senior notes due...

18d ago

EVH

Evolent Health management to meet with Truist

Meeting to be held in the Mid-Atlantic area on August 12 hosted by Truist. Published first on TheFly...

26d ago

EVH

Evolent Health reports Q2 EPS (10c) vs. 18c last year

Reports Q2 revenue $444.33M, consensus $459.43M. Seth Blackley, Co-Founder and Chief Executive Officer of Evolent stated, “Evolent exceeded...

29d ago

EVH

Evolent Health sees Q3 revenue $460M-$480M, consensus $538.6M

Sees Q3 adjusted EBITDA $34M-$42M. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial...

29d ago

EVH

Evolent Health cuts FY25 revenue view to $1.85B-$1.88B from $2.06B-$2.11B

FY25 consensus $2.06B. Narrows FY25 adjusted EBITDA view to $140M-$165M from $135M-$165M. Published first on TheFly – the...

29d ago

EVH

Evolent Health Closes $166.75M Convertible Notes Sale

Evolent Health ( ($EVH) ) just unveiled an update. On August 18, 2025, Evolent Health, Inc. entered into...

15d ago

EVH

Evolent Health Upsizes Convertible Notes Offering

Evolent Health ( ($EVH) ) just unveiled an update. On August 19, 2025, Evolent Health announced the pricing...

18d ago

EVH

Evolent Health’s Earnings Call: Balancing Growth and Challenges

Evolent Health Inc. (($EVH)) has held its Q2 earnings call. Read on for the main highlights of the...

24d ago

EVH

Evolent Health’s Strong Financial Performance and Optimistic Future Outlook Earns Buy Rating

Analyst Charles Rhyee from TD Cowen reiterated a Buy rating on Evolent Health and keeping the price target...

26d ago

EVH

Evolent Health Reports Q2 2025 Earnings and Growth Outlook

Evolent Health Inc. ( ($EVH) ) has released its Q2 earnings. Here is a breakdown of the information...

29d ago

EVH

EVH FAQ

What was Evolent Health’s price range in the past 12 months?

Evolent Health lowest stock price was $7.06 and its highest was $31.80 in the past 12 months.

What is Evolent Health’s market cap?

Evolent Health’s market cap is $1.12B.

When is Evolent Health’s upcoming earnings report date?

Evolent Health’s upcoming earnings report date is Oct 29, 2025 which is in 53 days.

How were Evolent Health’s earnings last quarter?

Evolent Health released its earnings results on Aug 07, 2025. The company reported -$0.1 earnings per share for the quarter, missing the consensus estimate of $0.074 by -$0.174.

Is Evolent Health overvalued?

According to Wall Street analysts Evolent Health’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Evolent Health pay dividends?

Evolent Health does not currently pay dividends.

What is Evolent Health’s EPS estimate?

Evolent Health’s EPS estimate is 0.09.

How many shares outstanding does Evolent Health have?

Evolent Health has 117,508,720 shares outstanding.

What happened to Evolent Health’s price movement after its last earnings report?

Evolent Health reported an EPS of -$0.1 in its last earnings report, missing expectations of $0.074. Following the earnings report the stock price went down -7.121%.

Which hedge fund is a major shareholder of Evolent Health?

Currently, no hedge funds are holding shares in EVH

Evolent Health Stock Smart Score

Neutral

Fundamentals

Return on Equity

-13.38%

Trailing 12-Months

Asset Growth

-0.55%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Evolent Health

Evolent Health (EVH) is a leading healthcare technology company that specializes in providing integrated solutions to health systems and payers. The company operates in the healthcare sector, focusing on value-based care models aimed at improving patient outcomes and reducing costs. Evolent Health offers a suite of services including care management, analytics, technology infrastructure, and population health management, enabling healthcare organizations to transition to value-based care while enhancing operational efficiencies.

Evolent Health (EVH) Earnings & Revenues

Historic Earnings Reports

EVH Company Deck

EVH Earnings Call

Q2 2025

0:00 / 0:00

Earnings Call Sentiment|Positive

Evolent's earnings call reflects a strong performance in adjusted EBITDA and promising new partnerships, including a notable agreement with Aetna. Despite some challenges in revenue guidance and exchange business headwinds, the company's progress in AI and automation, along with a robust business pipeline, suggests a positive outlook.View all EVH earnings summaries

EVH Stock 12 Month Forecast

Average Price Target

$15.25

▲(60.70% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"6":"$6","19":"$19","32":"$32","12.5":"$12.5","25.5":"$25.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":20,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$20.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":15.25,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$15.25</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":9.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$9.50</span>\n  </div></div>","useHTML":true}}],"tickPositions":[6,12.5,19,25.5,32],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Feb<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,9.98,10.750769230769231,11.521538461538462,12.292307692307693,13.063076923076924,13.833846153846155,14.604615384615386,15.375384615384615,16.146153846153847,16.916923076923077,17.68769230769231,18.45846153846154,19.229230769230767,{"y":20,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,9.98,10.385384615384616,10.79076923076923,11.196153846153846,11.601538461538462,12.006923076923076,12.412307692307692,12.817692307692308,13.223076923076924,13.628461538461538,14.033846153846154,14.439230769230768,14.844615384615384,{"y":15.25,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,9.98,9.943076923076923,9.906153846153847,9.86923076923077,9.832307692307692,9.795384615384616,9.758461538461539,9.721538461538461,9.684615384615384,9.647692307692308,9.61076923076923,9.573846153846153,9.536923076923078,{"y":9.5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":22.44,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":31.98,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27.05,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.46,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.71,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.25,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.45,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.99,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.68,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.95,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.57,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.63,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.98,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >